Senior insider sale
Chief Business Officer at ARBUTUS BIOPHARMA CORP — senior position signals high conviction
$170.1K
53.11K shares
What this filing means
MCELHAUGH MICHAEL J. plans to sell 53.11K shares of ARBUTUS BIOPHARMA CORP valued at approximately $170.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2025ACC: 0001965301-25-000045
Officer· Chief Business Officer
Since Dec 2018
53.11K
Shares to sell
$170.1K
Approx. market value
53.11K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Award
Compensation
9/26/2015
53.11KTotal acquired53.11K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/26/2015 | Stock Award Compensation | 53.11K | — |
| Total | 53.11K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
53.11K
Market value
$170.1K
4/15/2025
Total
Units
53.11K
Value
$170.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/15/2025 | 53.11K | $170.1K | NASDAQ | Planned |
| Total | 53.11K | $170.1K | ||